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KATZ, R. J. AND S. HERSH. Amitriptyline and scopolamine in an animal model of depression. NEUROSCI. 
BIOBEHAV. REV. 5(2) 265-271, 1981.--Adult male Sprague-Dawley rats were subjected to acute (95 dB white noise) or 
chronic stress, or their combination. In comparison with unstressed controls, stressed rats were more active upon several 
measures of open field activity. A history of chronic stress eliminated the acute stress induced activation. Concurrent 
treatment of chronically stressed rats with amitriptyline or scopolamine, or with a combination of both drugs resulted in 
selective behavioral improvement (i.e., in motor activity, latency, defecation) for amitriptyline and combined treatment 
rats, with significant restoration of the normal behavioral response. Scopolamine however was only marginally ef- 
fective. A higher dose of scopolamine proved effective, but only with a marked disruption of baseline activity. Examina- 
tion of plasma corticosterone titers indicated that chronic stress induced an elevation of basal levels and that this was 
reversed by amitriptyline, scopolamine, and combined drug treatment. Thus while behavioral depression and elevated 
corticosteroids may covary they are not identically mediated. 
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IN previous studies we have demonstrated the potential util- 
ity of a novel animal model of  depression based upon acute 
and chronic stress. While normal rats become hyperactive to 
acute noise stress this activation is not seen if tbey are chron- 
ically stressed beforehand. Only antidepressant drugs appear  
capable of  reversing the otherwise present reduction in acute 
stress elicited activity due to chronic stress. The model, 
along with most other models of its class (see Katz,  [8] for a. 
review) attempts to offer a simplified analog of  a complex 
clinical syndrome involving sadness, dejection, gloom, anx- 
iety, and psychosomatic  complaints. Clearly, not all these 
dimensions can be adequately encompassed in the rat, how- 
ever  the animal model, as has been demonstrated in previous 
papers in this series, does capture some of the typical retar- 
dation of  behavior and " loss  of environmental engagement" 
which also are frequently seen clinically. 
To date this model appears pharmacologically accurate 
and specific in its ability to identify drugs of established 
therapeutic benefit. Antidepressant  drugs, particularly tri- 
cyclic antidepressants,  possess modest to considerable 
anticholinergic properties.  It is unlikely that anticholinergic 
properties are sufficient to account for all behavioral im- 
provements in clinical depression or  the present model since 
monoamine oxidase inhibitors are behaviorally effective 
(e.g., [9]) but not strongly anticholinergic. Furthermore,  
cholinergic blockade is not considered an accepted or effec- 
tive therapy for depression [6]. 
Nonetheless,  two factors compel a more direct and de- 
tailed examination of  the effectiveness of anticholinergic 
drugs in the present model. As noted in previous reports,  
anticholinergic drugs have been falsely identified as 
antidepressants in other procedures [8] even in such behav- 
iorally sophisticated techniques as learned helplessness and 
behavioral despair  [ 1,3]. These last procedures of course are 
conceptually and behaviorally similar in a number of  ways to 
the present model. Thus, one critical test of  the specificity of 
the present model, and its empirical relation to previous 
models is the ability to distinguish anticholinergic drugs from 
true antidepressants.  
A second reason for testing a cholinergically active com- 
pound may be found in recent studies of the clinical 
psychobiology of  depression. Janowsky and Davis have 
suggested that increased cholinergic tone in consort with 
other, particularly adrenergic, hypofunctions may contribute 
to depressive affect in much the same way acetylcholine 
modulates dopamine in Parkinson's  syndrome [7]. The 
modulatory role is not necessarily exclusive, nor is it evident 
under all circumstances. A preexisting disturbance of affect 
or predisposition to illness may be necessary for a further 
psychobiologically significant role of  the cholinergic system. 
It is therefore of  interest to determine if cholinergic factors 
may modulate responses to antidepressants or any more 
specific aspects of  the depressive response. 
These and related issues were addressed using the pre- 
clinical model in the present experiments.  The first experi- 
ment replicated the depression effect which occurs after a 
history of  chronic stress, and examined the effects of  ami- 
triptyline, scopolamine, and their combination upon it. Ami- 
triptyline is a drug of  choice, particularly for agitated unipolar 
depression, and is in wide clinical use [11]. The drug has 
strong anticholinergic properties.  Scopolamine is an anti- 
cholinergic drug not typically considered useful in the clini- 
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cal pharmacotherapy of depression [6]. The combined group 
was included to assess whether a more subtle modulatory 
role for scopolamine was present in conjunction with other 
treatments.  In a second experiment,  the close of  scopolamine 
was increased by a factor of  five, to examine the effects of  
high drug dosages,  and whether more extreme pharmacolog- 
ical manipulations were potentially antidepressant.  
G E N E R A L  METHOD 
Subjects (double housed adult male Sprague Dawley rats; 
70 days each, Charles River Farms),  apparatus (a 1.22 m z 
white Plexiglas open field with 4x4  grid on the floor), and 
chronic and acute stress procedures were identical in all re- 
spects to previous descriptions. The acute stress procedure 
involved exposure of  individual rats to 95 dB of  white noise for 
1 hr prior to a 6 min placement in the open field. The chronic 
stress regimen followed that given in Katz  et al. [9] and is 
included in Table 1. The chronic stress regimen consisted of 
exposure to sixty minutes'  of  unpredictable shock (average 1 
mA, 1-10 sec duration; average 1 shock/minute (3 expo- 
sures)); 40 hours '  food deprivation (2 times); cold swim at 
4.0°C for 5 minutes (3 exposures);  40 hours '  water  depriva- 
tion (2 times); 5 minutes'  exposure to heat stress at 40*(2 (2 
times); 30 minutes '  shaker stress (2 times); reversal  of  
day/night cycle (2 times). Stressors were delivered in a 
semirandom fashion every 1-3 days throughout the day/night 
cycle from 0:800 through 22:00 hr. Order of  stress adminis- 
tration is presented in Table 1. 
Behavioral testing involved either of  two procedures.  
Control (basal) subjects were tested without further manipu- 
lations. Experimental subjects were exposed to an acute 
stress as described above. Control subjects were placed in 
the field without prestress.  The following experimental and 
control groups served as the basis for statistical compari- 
sons: (1) basal control conditions (vehicle injection, no his- 
tory of chronic stress prior to testing); (2) Chronically 
stressed control conditions (vehicle injection during chronic 
stress procedure);  (3) Amitryptyline groups (all chronically 
stressed); and (4) Scopolamine groups and combined drugs 
as described below. In Experiment 1, amitryptyline (5 
mg/kg/day), scopolamine (1 mg/kg/day), or their combination 
was administered for the three week stress period. All injec- 
tions were intraperitoneal, 1 ml/kg in 0.9% sodium chloride 
vehicle. Drugs were discontinued 36 hr prior to individual 
open field testing. At the close of the test rats were removed 
from the field and decapitated for collection of trunk blood 
for corticosterone assay by competitive protein binding 
assay using rat cort icosterone as assay standard and deter- 
minations in duplicate [10]. 
Behavioral measures were; initial (3 rain) activity in the 12 
outside squares of the field. All four feet were required to 
move from one square to a second for entry to be recorded; 
six minutes'  activity in inside squares by similar movement 
criterion; latency to leave home square (in seconds, 
maximum score=360 sec) bolus count; latency to initial def- 
ecation (in seconds, maximum score=360 sec), and mean 
ranks across categories, with all groups rank ordered from 
most to least active across all categories except bolus count 
and latency to move, in which case inverse rank orders were 
used. Statistical analysis by univariate analysis of  variance 
[4] followed previous descriptions, with post-hoc compari- 
sons by Sheffe limits. Results routinely are presented as 
means and standard errors. Because rearing proved unreli- 
able in all previous studies, it was not recorded in the present 
experiments.  
EXPERIMENT 1 
To initially investigate the comparative antidepressant 
potentials of  amitriptyline and scopolamine and their combi- 
nation in the behavioral model, low (for each drug ap- 
proximating behavioral ED-50's as determined using inde- 
pendent procedures [2]) doses of  these compounds were 
used in an incomplete factorial design. Control (vehicle) 
animals received chronic stress or no chronic treatment.  
Drug groups were chronically stressed. All groups were 
studied based upon control or acute stress procedures prior 
to behavioral testing. Thus a five (basal; chronic stress, ve- 
hicle; chronic stress, amitriptyline; chronic stress, scopola- 
mine; chronic stress, both drugs) by two (basal vs. acute 
stress) design was employed. 
Method 
Materials and methods conform to those presented in the 
General Method and previous studies. 
Results 
As in previous studies, acute noise stress initially ac- 
tivated otherwise unstressed rats. This activation effect was 
reduced by a history of antecedent stress, however the re- 
duction in turn was ameliorated by amitriptyline treatment 
but not by scopolamine which had a weak and less consistent 
antidepressant effect. These results are presented in detail 
below, and in Figs. 1 through 7. 
Locomotor  activity (outside squares; Fig. 1) differed reli- 
ably across groups, F(9,67)=6.4, p<0.0001. By post-boc 
comparisons (in all cases significance is based on a critical 

















= L  
B-B B-A C-B C-A 
I 
C-MBC-MA C-SBC-SA C-5MBO iMA 















t -  
el 
B-BB-A C-BC-A C-MBC-MA C-SBC-SA C-SMBC-SMA 
FIG. 1. Mean activity score plus standard error in an open field for 
rats receiving either no (basal=B) stress, acute (=A) stress of 95 dB 
white noise, or a history of 3 weeks chronic (=C) stress along with 
the tricyclic antidepressant amitriptyline (M) 5 mg/kg/day, the anti- 
cholinergic drug scopolamine 1 mg/kg/day (S) or their combinaton 
(SM). The leftmost two columns are the non-chronically stressed 
control, i.e., rats receiving no stress (left) or acute stress (right); 2nd 
set of columns from left is chronically stressed, 3rd set of columns 
from left is chronically stressed with amitriptyline, 4th set of col- 
umns is chronically stressed with scopolamine, final set of columns 
is chronically stressed with both drugs. The convention of no acute 
stress; acute stress in left, right order is used throughout. Initial 
three minutes' grid crossings are recorded during a single placement 
in the field. 
FIG. 2. Center field penetration in an open field. Mean score plus 
standard error for a six minute placement are shown. Rats received 
acute or chronic stress with three drug treatments in conjunction 
with the latter. B=basal (not stressed), A=acutely stressed for 1 hr, 
M=chronically treated with amitriptyline, S=chronically treated 
with scopolamine. The leftmost two columns are the non-chronically 
stressed control i.e. rats receiving no stress (left) or acute stress 
(right); 2nd set of columns from left is chronically stressed, 3rd set of 
columns from left is chronically stressed with amitriptyline, 4th set 
of columns is chronically stressed with scopolamine, final set of 
columns is chronically stressed with both drugs. The convention of 
no acute stress; acute stress in left, right order is used throughout. 
difference smaller than p<0.05) indicated this was due to 
acute (60 min) stress-induced increases in activity specific to 
otherwise untreated (i.e., vehicle injected) rats (F=8.0). The 
activation affect also was seen in amitriptyline treated chron- 
ically stressed rats (F=I5.1) and in chronically treated rats 
receiving combined treatment (F= 15.9). Chronically 
stressed saline or scopolamine treated rats did not show an 
acute activation (F=2.0, 2.5; n.s.). 
Inside squares (Fig. 2) did not show a significant main 
effect, F(9,67)=2.4, p =0.2, precluding further analysis. 
Initial Movement Latency Scores (Fig. 3) showed reliable 
group differences, F(9,67)=4.3, p<0.0002. Latency to 
movement was significantly reduced in vehicle treated rats 
by acute stress (F=II .2) .  Acute stress was marginally but 
not significantly effective in chronically stressed rats 
(F=l .9) .  Amitriptyline and combined drug treatment re- 
stored normal responsiveness to acute stress in chronically 
treated rats (F=6.9, 7.7). This effect was not present with 
scopolamine (F=2.2). 
Defecation scores (Mean Bolus Count: Fig. 4) differed 
across groups, F(9,67)=3.2, p<0.005, with significant stress 
induced reductions in vehicle treated rats (F=4.4) and ami- 
triptyline treated rats (F=7.8). This acute stress induced re- 
duction in normal defecation was absent after other chronic 
stress treatments (for vehicle, scopolamine, and combined 
drug F ' s <  1). 
Analysis of defecation latency (Fig. 5) indicated a signifi- 
cant groups effect, F(9,67)=3.8, p<0.001. Latencies were 
increased by acute stress in vehicle treated control rats 
(F=4.6) but not in chronically stressed rats (F ' s< l ) .  Ami- 
triptyline restored the latency increase (F=6.9) while 
scopolamine and a combination of drugs were not effective 
(both F ' s < l ) .  
Corticosterone data (Fig. 6) provided supplementary sup- 
port for the above findings. An overall effect of groups was 
evident, F(9,67)=6.1, p<0.0001. For all groups (acute, 
chronic vehicle, amitriptyline, scopolamine, combined), 
acute stress produced a significant elevation of circulating 
corticosteroids (F=6.1, 4.9, 6.3, 6.0, 5.8, respectively). It 
might also be noted that chronic stress elevated basal steroid 
levels in comparison with rats not receiving the three week 
procedure (F=3.7) and this was restored to baseline by 
amitriptyline, scopolamine and their combined treatment 
(F--3.6, 3.0, 2.7). 
Finally, Fig. 7 presents an analysis of composite mean 
scores across categories based upon relative ranks. The 
major findings from this last analysis are an increased overall 
level of activation in otherwise basal rats (F= 14.0) which 




h i  





























B-B B-A C-B C-A C-MBC-MA C-SBC-SA C-SMBC-SMA 
FIG. 3. Mean latencies (in sec) to initial activity in an open field plus 
standard errors. Rats received acute or  chronic stress,  with three 
drug treatments  in conjunction with the latter. The leftmost two 
columns are the non-chronically stressed control,  i.e., rats receiving 
no stress (left) or acute stress (right); 2rid set o f  columns from left is 
chronically stressed,  3rd set o f  columns from left is chronically 
stressed with amitriptyline, 4th set of  columns is chronically 
stressed with scopolamine, final set o f  columns is chronically 
stressed with both drugs. The convention of  no acute stress; acute 
stress in left, right order  is used throughout.  Complete figure legend 
is presented in Fig. 1. 
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FIG. 4. Mean defecation score in an open field plus standard error. 
Bolus count is presented.  Rats received either acute or  chronic 
stress,  with three drug treatments in conjunction with the latter. The 
leftmost two columns are the non-chronically stressed control,  i.e., 
rats receiving no stress (left) or  acute stress (right); 2nd set o f  col- 
umns from left is chronically s tressed,  3rd set o f  columns from left is 
chronically stressed with amitriptyline, 4th set o f  columns is chroni- 
cally stressed with scopolamine,  final set o f  columns is chronically 
stressed with both drugs. The convention of  no acute stress; acute 
stress in left, right order  is used throughout.  Complete figure legend 
is presented in Fig. 1. 
FIG. 5. Mean defecation latencies (in sec) in an open field plus 
standard errors.  Rats received either acute or chronic stress,  with 
three drug treatments  in conjunction with the latter. The leftmost 
two columns are the non-chronically stressed control,  i.e., rats re- 
ceiving no stress (left) or acute stress (right); 2nd set o f  columns 
from left is chronically stressed,  3rd set o f  columns from left is 
chronically stressed with amitriptyline, 4th set o f  columns is chroni- 
cally s tressed with scopolamine,  final set o f  columns is chronically 
stressed with both drugs. The convention of  no acute stress: acute 
stress in left, right order  is used throughout.  Complete figure legend 
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FIG. 6. Mean plasma cort icosterone levels (in/~g/dL) plus standard 
errors. All rats were exposed to acute or  chronic stress,  with three 
drug treatments  in conjunction with the latter. A six minute open 
field test was followed by immediate removal and decapitation. 
Trunk blood was collected and used in competi t ive protein binding 
assay as described in text. Complete figure legend is presented in 
Fig. 1. The leftmost two columns are the non-chronically stressed 
control,  i.e., rats receiving no stress (left) or  acute stress (right); 2nd 
set o f  columns from left is chronically stressed,  3rd set o f  columns 
from left is chronically stressed with amitriptyline, 4th set o f  col- 
umns is chronically stressed with scopolamine,  final set o f  columns 
is chronically stressed with both drugs. The convent ion o f  no acute 
stress; acute stress in left, right order  is used throughout.  
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FIG. 7. Composite activity score for open field activity of rats in 
Experiment 1. The leftmost two columns are the non-chronically 
stressed control, i.e., rats receiving no stress (left) or acute stress 
(right); 2nd set of columns from left is chronically stressed, 3rd set of 
columns from left is chronically stressed with amitriptyline, 4th set 
of columns is chronically stressed with scopolamine, final set of 
columns is chronically stressed with both drugs. The convention of 
no acute stress; acute stress in left, right order is used throughout. 
Scores calculated as mean relative ranks across categories. 
the dosages reported effective in both these last studies are 
close to or identical with the dose used in the present study. 
Since different species, stress histories, courses of drug ad- 
ministration and testing procedures were employed it should 
not be surprising that the present and previous models also 
differ pharmacologically. 
E X P E R I M E N T  2 
Experiment 1 suggested that while amitriptyline was an 
effective treatment in the present model, scopolamine was 
not. Cholinergic blockade brought about modest  but unreli- 
able behavioral improvements.  The dose of  scopolamine was 
effective as judged both from other related treatments (e.g., 
[1, 2, 3] and the above endocrine data). It is possible that a 
higher degree of  anticholinergic activity is necessary for be- 
havioral effects. The second experiment increased the dose 
of scopolamine fivefold, and examined effects using a facto- 
rial design. 
Method 
Subjects, apparatus and behavioral procedure were iden- 
tical to previous description. A complete 2 × 2 x 2  factorial 
design (presence vs. absence of acute stress, presence vs. 
absence of  chronic stress, vehicle vs. drug) was employed 
using a higher dose (5 mg/kg/day) of scopolamine. Cortico- 
sterone was not analyzed at the close of the experiment.  
was significantly reduced by chronic stress (F=3.1) ,  and 
chronic stress with scopolamine treatment (F= l .7 ) .  Both 
amitriptyline (F=10.1) and combined drug treatment 
(F=25.0) were effective in restoring the acute stress re- 
sponse in chronically stressed rats. 
Discussion 
In the first experiment amitriptyline significantly im- 
proved otherwise depressed open field activation, and re- 
duced a concomitant elevation of basal corticosterone levels. 
The anticholinergic drug was less effective in altering behav- 
ior although it too restored pituitary-adrenal activity towards 
normal. Combined drug treatment more closely resembled 
amitriptyline, but was slightly less effective. 
To test the influence of anticholinergic factors in the res- 
toration of  function, drug doses were initially equated as 
behavioral ED-50's. If  anticholinergic factors were sufficient 
for an antidepressant response,  both treatments should have 
been equally effective. They clearly were not. It follows 
other factors must be involved in the reversal effect. Exam- 
ination of corticosterone data indicated that both treatments 
were roughly equivalent at an endocrine level. Cholinergic 
neurons therefore may normally enhance pituitary-adrenal 
responsiveness in chronic stress and be sufficient for the 
reported endocrine effects but not behavioral improvements.  
This finding suggests a more limited role for cholinergic fac- 
tors and emphasizes that, at least upon certain criteria, the 
drugs indeed were roughly equivalent. These last results on 
pituitary-adrenal control in rats are also consistent with 
studies on the normal regulation of  pituitary adrenal activity 
in humans [5]. 
These findings stand in contrast  to other reports using 
related behavioral approaches.  Cholinergic antagonists have 
been reported effective in the learned helplessness model [ I] 
and in behavioral despair  [3]. It should be emphasized that 
Results 
The findings confirm the existence of stress elicited 
arousal and its reduction by chronic stress. Very high doses 
of scopolamine eliminated the otherwise present depression 
of open field activity and alterations in defecation measures,  
but only with a concomitant nonspecific disruption of 
baseline activity. The findings are presented below and in 
Figs. 8-11. 
Locomotor  activity (Fig. 8; outside squares/three min- 
utes) was reliably different across cells, F(7,40)=5.5, 
p<0.001,  with significant stress induced elevations in 
otherwise basal rats (F=5.6) which were eliminated by 
chronic stress ( F ' s < l ) .  All scopolamine groups were ele- 
vated from a nonstress nondrugged baseline (F ' s  respec- 
t ively=6.0,  11.6, 8.6, 13.4 for basal and stressed groups with 
and without chronic stress). None of  the last groups differed 
among themselves (in all cases F ' s < l ) .  Thus, while vehicle 
treated rats showed a typical pattern of  activity and activity 
reduction, high doses of drug produced an elevation in activ- 
ity unrelated to acute or chronic stress. 
Inside squares were not significantly altered by the treat- 
ment conditions, F(7,40)=0.9, precluding further analysis. In 
the interest of brevity, the data are not presented in greater 
detail. 
Initial motor latency (Fig. 9) was reliably different across 
cells, F(7,40)=4.8, p<0.001.  Activity was reduced in other- 
wise basal rats by acute stress (F---7.9). It was significantly 
reduced in chronically stressed rats as well (F=9.8) but to a 
reliably smaller degree (F=3.9).  In all cases but chronic 
stress without acute stress, scopolamine groups were reli- 
ably different from basaUy unstressed groups (F=6.9,  9.2, 
0.1, 5.2). Since scopolamine had its most pronounced effect 
upon unstressed rats and there are no reliable differences 
( F ' s <  1) in the responses of  drug treated animals with respect 
to a prior history of  chronic stress, this supports a 
nonspecific interpretation of the results. 
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FIG. 8. Mean locomotor activity (outside squares/3 rain) plus stand- 
ard error in a 2x2x2 factorial design (Acute stress (A) vs. Basal (B); 
3 weeks' chronic stress (C) vs. Basal (B); Scopolamine (S) 5 
mg/kg/day during chronic stress vs. vehicle). 
FIG. 10. Mean defecation score (bolus count) plus standard error in 
an open field in a 2x2x2 factorial design using a higher dose of 
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FIG. 9. Mean latencies (in sec) to initial activity plus standard error 
in a 2x2x2 factorial design using a higher dose of scopolamine. 
Figure legend is further described in Figs. I and 8. 
Defecation scores (Fig. 10) also differed from each other 
in statistically reliable fashion, F(7,40)=4.6, p<0.001,  based 
upon significant acute stress induced reductions of  defeca- 
tion in otherwise basal rats (F=5.7) ,  which in turn were sig- 
nificantly reduced from this level by chronic stress (F=8.2) ,  
and were not themselves significant. Scopolamine was ef- 
fective in restoring the normal stress induced inhibition in 
both basal and chronically stressed rats ( F ' s =  15.5, 6.8). 
Defecation latencies (Fig. 11)followed a similar pattern 
(F for main effect=3.8,  p<0.005).  Stress effects were reli- 
ably present for both non-chronically treated acutely 
stressed groups in comparison to basal controls (F ' s=0 .2 ,  
1.3, respectively,  for vehicle and scopolamine), indicating a 
drug effect upon baseline but no antidepressant effects for 
scopolamine on this last measure. 
Discussion 
The second experiment utilized a higher dose of 
scopolamine than the first experiment,  but did not find a 
general reversal of open field depression similar to that seen 
with amitriptyline in the first experiment.  Rather, sco- 
polamine 's  effects upon behavior reflected nonspecific 
disinhibition. The present results suggest either that 
antidepressant effects were absent on individual measures,  
or that such effects occurred only with grossly aberrant be- 
havioral baselines. Thus, the results cannot reasonably be 
attributed to effects unique to the chronic stress procedure.  
These findings argue for caution in ascribing preclinical 
antidepressant potential to anticholinergics and suggest a 
continuing need to examine effects from the vantage point of  
both normal and abnormal behavioral baselines. 
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FIG. 11. Mean defecation latency (in sec) plus standard error, in an 
open field in a 2x2x2 factorial design using a higher dose of 
scopolamine. Figure legend is further described in Figs. 1 and 8. 
GENERAL DISCUSSION 
Only limited evidence supports a direct cholinergic role in 
the clinical symptomatoiogy of depression [6,7]. We do not 
deny the existence of cholinergic factors in depression, how- 
ever they must be seen as one category of effect in a more 
complex biological disruption. Cholinergic neurons may well 
modulate endocrine control in the animal model of depres- 
sion, and their blockade may have a mild but limited degree 
of behavioral benefit. Cholinergic blockade per se, however, 
is clearly less effective in the present model than amitrip- 
tyline, a tricyclic drug with anticholinergic properties. These 
results further suggest the animal model is accurate, specific, 
and at least to a degree distinctive from other animal models. 
In closing however we reemphasize that the model is lim- 
ited in its characterization of the far more complex clinical 
presentation of depression in humans. Insofar as rats show 
some behaviors analogous to human coping the present 
model seems to embody at least certain common factors. It is 
not our present intention to augue for strict isomorphic cor- 
respondence but rather for the existence of some common 
ground between the laboratory model and clinical findings 
which can be used for further investigation. 
ACKNOWLEDGMENTS 
The statistical assistance of Robert Shea and editorial assistance 
of Abe Feingold are acknowledged with thanks. Portions of this 
work were carded out by the second author in partial fulfillment of a 
graduate course requirement in psychology (No. 619) at the Univer- 
sity of Michigan. Supported by grant MH 31588 to Drs. B. J. Carroll 
(primary investigator) and R. J. Katz (co-investigator). Dr. Katz is a 
Sioan Foundation Fellow. 
REFERENCES 
I. Anisman, H., G. Remington and L. S. Sklar. Effect of inescap- 
able shock on subsequent escape performance catechola- 
minergic and cholinergic mediation of response initiation and 
maintenance. Psychopharmacology 61: 107-124, 1979. 
2. Barnes, C. D. and L. G. Eltherington. Drug Dosage in Labora- 
tory Animals. Berkeley, Calif.: University of California Press, 
1964. 
3. Browne, R. G. Effects of antidepressants and anticholinergics in 
a mouse "behavior despair" test. Eur. J Pharmac. 58: 331-334, 
1979. 
4. Bruning, J. L. and B. L. Klintz. Computational Handbook of 
Statistics, 2nd edition. Glenview, Iii.: Scott Foresman Co., 
1977. 
5. Carroll, B. J., J. F. Greden, R. Haskett, M. Feinberg, A. A. 
Albala, F. I. R. Martin, R. T. Rubin, B. Heath, P. T. Sharp, W. 
L. McLeod and M. F. McLeod. Neurotransmitter studies of 
neuroendocrine pathology in depression. Acta psych, scand. 61 
(Supp 280) 183-200, 1980. 
6. Innes, I. R. and M. Nickerson. Atropine, scopolamine, and re- 
lated antimuscarinic drugs. In: The Pharmacological Basis of 
Therapeutics, edited by L. S. Goodman and A. Gilman. New 
York: MacMillan, 1975, pp. 514-532. 
7. Janowsky, D. S. and J. M. Davis. Psychological effects of 
cholinominetic agents. In: Brain Acetylcholine and Neuro- 
psychiatric" Disease, edited by K. L. Davis and P. A. Berger. 
New York: Plenum Press, 1979, pp. 3--14. 
8. Katz, R. J. Animal models and human depressive disorders. 
Neurosci. Biobehav. Rev. 5: 231-246, 1981. 
9. Katz, R. J., K. A. Roth and K. Schmaltz. Amphetamine and 
tranylcypromine in an animal model of depression: Pharma- 
cological specificity of the reversal effect. Neurosci. Biobehav. 
Rev. 5: 259-264, 1981. 
10. Murphy, B. E. P. Some studies of the protein binding of steroids 
and their application to the routine micro and ultra micro meas- 
urement of various steroids in body fluids by competitive 
protein binding radioassay. J. clin. Endoer. 27: 973-990, 1967. 
! 1. Van Praag, H. M. Psychotropic Drugs--A Guide for the Practi- 
tioner. New York: Brunning/Mazel Inc., 1978. 
